Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ACTH1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 13, 66, 145, 222 💬
2ACTH (Acthar) Gel1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66 💬
3Acthar1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222 💬
4Acthar 80 unit injection1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66 💬
5Acthar Gel1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 46, 49, 50, 84, 222 💬
6ACTHAR Gel (ACTH)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
7ACTHAR Gel (adrenocorticotropic hormone)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
8ACTHAR Gel 40 units twice weekly1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
9ACTHAR Gel 80 units twice weekly.1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
10Acthar high dose (80 U)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49 💬
11Acthar Injectable Product1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 46 💬
12Acthar low dose (40 U)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 49 💬
13ActHIB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen (ActHIB)---2件: 62, 66 💬
14ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen (ActHIB)---2件: 62, 66 💬
15Acthrel1件: Corticorelin ovine triflutate (Ovine ACTH releasing factor)1件: Corticorelin ovine triflutate (Acthrel (TN)) 💬 2件: CRHR1,
CRHR2 💬
4件: Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
16Adrenocorticotrophic hormone ACTH1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222 💬
17Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
18Corticotropin
(ACTH (TN))
1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 2, 13, 46, 75, 81, 84, 222 💬
19Corticotropin-releasing hormone
(ACTH (TN))
2件: Corticorelin,
Corticotropin (Acthar Powder Inj 40unit/vial)
2件: Corticotropin (ACTH (TN)),
Corticorelin 💬
3件: CRHR1,
CRHR2,
MC2R 💬
6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
20Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.
(ACTH (TN))
1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
21H.P. Acthar Gel1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 46, 49, 50, 84, 222 💬
22H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
23H.P. Acthar® Gel1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14 💬
24Ovine Corticotropin-Releasing Hormone (oCRH)
(ACTH (TN))
2件: Corticorelin,
Corticotropin (Acthar Powder Inj 40unit/vial)
2件: Corticotropin (ACTH (TN)),
Corticorelin 💬
3件: CRHR1,
CRHR2,
MC2R 💬
6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
25Repository Corticotropin Injection
(ACTH (TN))
1件: Corticotropin (Acthar Powder Inj 40unit/vial)1件: Corticotropin (ACTH (TN)) 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 2, 13, 46, 84, 222 💬